Cargando…

Oxidative Stress, Inflammatory, Angiogenic, and Apoptotic molecules in Proliferative Diabetic Retinopathy and Diabetic Macular Edema Patients

The aim of this study is to evaluate molecules involved in oxidative stress (OS), inflammation, angiogenesis, and apoptosis, and discern which of these are more likely to be implicated in proliferative diabetic retinopathy (PDR) and diabetic macular edema (DME) by investigating the correlation betwe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrés-Blasco, Irene, Gallego-Martínez, Alex, Machado, Ximena, Cruz-Espinosa, Javier, Di Lauro, Salvatore, Casaroli-Marano, Ricardo, Alegre-Ituarte, Víctor, Arévalo, José Fernando, Pinazo-Durán, María Dolores
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179600/ https://www.ncbi.nlm.nih.gov/pubmed/37175931 http://dx.doi.org/10.3390/ijms24098227

Ejemplares similares

Vitreous inflammatory and angiogenic factors on patients with proliferative diabetic retinopathy or diabetic macular edema: the role of Lipocalin2
por: Batsos, Georgios, et al.
Publicado: (2022)

Update on the Effects of Antioxidants on Diabetic Retinopathy: In Vitro Experiments, Animal Studies and Clinical Trials
por: Garcia-Medina, Jose Javier, et al.
Publicado: (2020)

Therapeutic Interventions against Inflammatory and Angiogenic Mediators in Proliferative Diabetic Retinopathy
por: Gologorsky, Daniel, et al.
Publicado: (2012)

Angiogenic and Vasculogenic Factors in the Vitreous from Patients with Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy
por: Graham, Patricia S., et al.
Publicado: (2018)

Wide-field imaging in proliferative diabetic retinopathy
por: Liu, T. Y. Alvin, et al.
Publicado: (2019)

Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy
por: Marques, Ines P., et al.
Publicado: (2020)

Angiogenic Potential of Vitreous from Proliferative Diabetic Retinopathy and Eales' Disease Patients
por: Murugeswari, Ponnalagu, et al.
Publicado: (2014)

Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2018)

Outcomes of 25-Gauge Vitrectomy for Tractional and Nontractional Diabetic Macular Edema with Proliferative Diabetic Retinopathy
por: Someya, Hideaki, et al.
Publicado: (2019)

Intravitreal Injection for Diabetic Macular Edema as Adjunctive Therapy for Proliferative Diabetic Retinopathy: A Retrospective Study
por: Aljundi, Wissam, et al.
Publicado: (2022)

Update on Management of Non-proliferative Diabetic Retinopathy without Diabetic Macular Edema; Is There a Paradigm Shift?
por: Arabi, Amir, et al.
Publicado: (2022)

Aflibercept for long-term treatment of diabetic macular edema and proliferative diabetic retinopathy: a meta-analysis
por: Xie, Xiao, et al.
Publicado: (2023)

Correlations Between Different Angiogenic and Inflammatory Factors in Vitreous Fluid of Eyes With Proliferative Diabetic Retinopathy
por: Wu, Guanrong, et al.
Publicado: (2021)

Heritability of Proliferative Diabetic Retinopathy
por: Hietala, Kustaa, et al.
Publicado: (2008)

Proliferative diabetic retinopathy in acromegaly
por: Malhotra, Chintan
Publicado: (2010)

Ranibizumab Pretreatment in Vitrectomy with Internal Limiting Membrane Peeling on Diabetic Macular Edema in Severe Proliferative Diabetic Retinopathy
por: Guan, Jian, et al.
Publicado: (2020)

Proliferative Diabetic Retinopathy Events in Patients With Diabetic Macular Edema: Post Hoc Analysis of VISTA and VIVID Trials
por: Do, Diana V., et al.
Publicado: (2022)

Laser Photocoagulation Combined with Intravitreal Triamcinolone Acetonide Injection in Proliferative Diabetic Retinopathy with Macular Edema
por: Choi, Kyung Seek, et al.
Publicado: (2007)

Inflammatory and angiogenic biomarkers in diabetic retinopathy
por: Kaštelan, Snježana, et al.
Publicado: (2020)

Association of Subregional Quantitative Ultra-widefield Fluorescence Angiography Characteristics With the Occurrence of Diabetic Macular Edema and Proliferative Diabetic Retinopathy
por: Sun, Gongpeng, et al.
Publicado: (2021)

Growth Factors in Proliferative Diabetic Retinopathy
por: Khan, Zia Ali, et al.
Publicado: (2003)

Candidate Genes for Proliferative Diabetic Retinopathy
por: Petrovič, Daniel
Publicado: (2013)

Predicting Development of Proliferative Diabetic Retinopathy
por: Harris Nwanyanwu, Kristen, et al.
Publicado: (2013)

The Effects of Pleiotrophin in Proliferative Diabetic Retinopathy
por: Zhu, Xuemei, et al.
Publicado: (2015)

Refining vitrectomy for proliferative diabetic retinopathy
por: Chen, San-Ni, et al.
Publicado: (2023)

Proliferative diabetic retinopathy transcriptomes reveal angiogenesis, anti-angiogenic therapy escape mechanisms, fibrosis and lymphatic involvement
por: Korhonen, Ani, et al.
Publicado: (2021)

Serum molecular signature for proliferative diabetic retinopathy in Saudi patients with type 2 diabetes
por: Pan, Jianbo, et al.
Publicado: (2016)

Macular Edema Formation and Deterioration of Retinal Function after Intravitreal Bevacizumab Injection for Proliferative Diabetic Retinopathy
por: Imai, Hisanori, et al.
Publicado: (2011)

Intravitreal Bevacizumab as Anti-Vascular Endothelial Growth Factor in the Management of Complications of Proliferative Diabetic Retinopathy
por: Fernando Arevalo, J.
Publicado: (2013)

Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy
por: Chernykh, VV, et al.
Publicado: (2015)

Postvitrectomy diabetic vitreous hemorrhage in proliferative diabetic retinopathy
por: Shi, Lei, et al.
Publicado: (2012)

The Patient Experience with Diabetic Retinopathy: Qualitative Analysis of Patients with Proliferative Diabetic Retinopathy
por: Sherman, Steven A., et al.
Publicado: (2022)

Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy
por: Perais, Jennifer, et al.
Publicado: (2023)

Diabetic macular edema and proliferative diabetic retinopathy treated with anti-vascular endothelial growth factor under the reimbursement policy in Taiwan
por: Hsieh, Ming-Chieh, et al.
Publicado: (2022)

The association between different hypoglycemic regimens and postoperative diabetic macular edema after vitrectomy in the Japanese patients with proliferative diabetic retinopathy
por: Lei, Chunyan, et al.
Publicado: (2022)

High-Mobility Group Box-1 and Endothelial Cell Angiogenic Markers in the Vitreous from Patients with Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2012)

Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
por: Babapoor-Farrokhran, Savalan, et al.
Publicado: (2015)

Role of combined phacoemulsification and intravitreal injection of bevacizumab in prevention of postoperative macular edema in non-proliferative diabetic retinopathy
por: Khodabandeh, Alireza, et al.
Publicado: (2018)

Effect of topical nepafenac in prevention of macular edema after cataract surgery in patients with non-proliferative diabetic retinopathy
por: Sarfraz, Muhammad Haroon, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_md1bqn8oqbcttpi5hqcmdbojdk